Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2697183rdf:typepubmed:Citationlld:pubmed
pubmed-article:2697183lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2697183lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:2697183lifeskim:mentionsumls-concept:C2931822lld:lifeskim
pubmed-article:2697183lifeskim:mentionsumls-concept:C0376249lld:lifeskim
pubmed-article:2697183lifeskim:mentionsumls-concept:C0039260lld:lifeskim
pubmed-article:2697183pubmed:issue6lld:pubmed
pubmed-article:2697183pubmed:dateCreated1990-4-12lld:pubmed
pubmed-article:2697183pubmed:abstractTextIn order to assess the association between human leukocyte antigens (HLA) and nasopharyngeal carcinoma (NPC), a total of 10 familial and 10 sporadic NPC patients and 171 unrelated healthy controls were studied. HLA typing was performed using commercial trays which defined 30 specificities of HLA-A, B and C loci and 10 specificities of HLA-D locus according to the method of Tiwari and Terasaki. HLA-A2, B16 and DR1 were found to be higher among patients with NPC than unrelated healthy controls with an odds ratio (OR) and a 95% confidence interval of 5.91 (2.1-16.6), 6.00 (2.0-18.0) and 6.89 (1.3-37.5), respectively. Further analysis showed that A2(+) B16(+) haplotype was significantly associated with a much higher risk of NPC (OR = 15.5) as compared with A2(-) B16(-) haplotype. No difference in frequency distributions of HLA-A, B, C and D antigens was observed between familial and sporadic NPC patients.lld:pubmed
pubmed-article:2697183pubmed:languageenglld:pubmed
pubmed-article:2697183pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2697183pubmed:citationSubsetIMlld:pubmed
pubmed-article:2697183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2697183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2697183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2697183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2697183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2697183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2697183pubmed:statusMEDLINElld:pubmed
pubmed-article:2697183pubmed:issn0250-7005lld:pubmed
pubmed-article:2697183pubmed:authorpubmed-author:HsiehTTlld:pubmed
pubmed-article:2697183pubmed:authorpubmed-author:HsuM MMMlld:pubmed
pubmed-article:2697183pubmed:authorpubmed-author:PaeWWJrlld:pubmed
pubmed-article:2697183pubmed:authorpubmed-author:HwangS JSJlld:pubmed
pubmed-article:2697183pubmed:authorpubmed-author:ChenC JCJlld:pubmed
pubmed-article:2697183pubmed:authorpubmed-author:HsiehR PRPlld:pubmed
pubmed-article:2697183pubmed:authorpubmed-author:ChangA SASlld:pubmed
pubmed-article:2697183pubmed:issnTypePrintlld:pubmed
pubmed-article:2697183pubmed:volume9lld:pubmed
pubmed-article:2697183pubmed:ownerNLMlld:pubmed
pubmed-article:2697183pubmed:authorsCompleteYlld:pubmed
pubmed-article:2697183pubmed:pagination1649-53lld:pubmed
pubmed-article:2697183pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:meshHeadingpubmed-meshheading:2697183-...lld:pubmed
pubmed-article:2697183pubmed:articleTitleHuman leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan.lld:pubmed
pubmed-article:2697183pubmed:affiliationInstitute of Public Health, National Taiwan University College of Medicine, Taipei.lld:pubmed
pubmed-article:2697183pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2697183pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2697183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2697183lld:pubmed